EditorialClin Res Hepatol Gastroenterol2021
The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients.
- Journal
- Clin Res Hepatol Gastroenterol
- Published
- 24 June 2020
- Citations
- 6
- Type
- Editorial
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try